Media platforms in Mexico have experienced tremendous growth over the past years and a significant number of individuals in the country, including millennials, are known to use the various social media platforms. In the late 1990`s, there were already over two hundred and fifty television stations which were broadcasting to the relatively fair number of individuals with tv sets. Grupo Televisa was one of the most public video platforms in those days and has continued to provide various shows and forms of entertainment to its viewers. Due to a large number of individuals watching television and using other social media platforms, many companies are striving to develop and expand themselves to have competence among their competitors. The various leaders and managers of such platforms are currently employing strategies to deliver the best to their viewers.
Alfonso De Angoitia is one of the most famous and highly skilled leaders of a leading media platform in Mexico. Alfonso plays a role as the director and executive vice president of Grupo Televisa, which is considered to be the largest media platform in the nation. He was born in 1962 and has over the past years helped to transform the operations of the rich media platform. Alfonso has been on the board of management of the company since the late 1990`s before acting as an independent member of the board of directors. He was later appointed the chairman of the of Grupo Televisa`s finance committee, among other members. Besides, Alfonso has also played a role as an alternate member of the board of directors at Univision.
Before joining Grupo Televisa, Alfonso worked at white and case LLC in Newyork city before becoming a founding partner member in Mijares. He is considered to be an amendable financialist of Grupo Televisa, and through his advice as well as help, he enabled the company attracts a large number of people in Mexican market through its partnership with Univision and other companies.
What disease is the leading cause of disability in the U.S. afflicts fifty-million people and is a degeneration of the soft tissue (cartilage) between the bones? Osteoarthritis, a.k.a. Degenerative Joint Disease.
Osteoarthritis is caused by things that can be governed like obesity that places extra stress on the joints and smoking which is detrimental to the connective tissues. Then there are the risk factors that can’t be controlled: genetics injury and aging.
There is no cure for OA. There are ways to mitigate the pain and swelling. Morning immobility can be avoided by stretching and light exercise before turning in. When awake stand-up and walk around every thirty minutes. Movement is imperative. Utilize low impact aerobic exercise and stretching to ease symptoms. Walking biking and swimming are recommended activities.
People who live in the Monmouth County New Jersey area can turn to the Osteo Relief Institute of New Jersey (http://www.edgewaterosteoreliefinstitute.com/). The Osteo Relief Institute uses the most modern FDA approved treatments and diagnostic procedures. Videofluoroscopy x-rays the joint while it is in motion more accurately pinpointing the arthritic area.
The Osteo Relief Institute has board certified doctors and physical therapist on staff. Explanations of your condition and potential treatments are given in plain English (HealthGrades). The Osteo Relief Institute uses a variety of treatments that work together to achieve maximum relief of symptoms. Biomechanical bracing lubricating injections and “Non-Grueling” spine and knee strengthening among them.
The objective of the Osteo Relief Institute is to provide relief by trying to avoid invasive procedures. Among the conditions that can be treated at the Osteo Relief Institute are chronic back pain, herniated and bulging discs, Spinal Stenosis, neck problems, sciatica, neuropathy, degenerative disc disease, and failed back surgery.
Minimizing the cost of treatment is another of the Osteo Relief Institute’s objectives. Initial screenings are free.
More about Osteo Relief Institute here
Oncotarget is an organization that publishes research type papers concerning Oncology as well as Cancer Research. In addition, Oncotarget also publishes well researched papers concerning Endocrinology as well as Pathology.Essentially, Oncotarget publishes medical material which is helpful to physicians as well as medical students. Such material can provide new insight into medical treatment as well as potential cures which are not known to the public.There are other areas in which Oncotarget publishes updated material. Other areas of research and interest include Cell Diseases and Endocrine Immunology.
You may also contact Oncotarget directly for information regarding article submission guidelines, publication fees as well as publishing policies. In addition, manuscripts may be submitted concerning a variety of medical topics. Once manuscripts are submitted a review process takes place which could take up to 3 months.Group Authorship opportunities are also available through Oncotarget. Essentially, one or more authors must be identified once a manuscript is approved for publication. In addition, if more than one author is identified and associated with a particular article then all parties names will be listed as the original creator and or publisher of the article.
*Article Submission Guideline Information:
Article submissions require complete and updated contact information, identifiable sources (where information was gathered), as well as reason for wanting to publish a specific article. Some articles are published for research purposes. Some articles are published and used as teaching tools for undergraduate medical students.There are special policies concerning any animal related articles. Articles that may involve any form of animal testing must go through an intensive approval and or verification process. All testing must be in accordance with current laws regarding animal testing.Finally, Oncotarget is a useful resource for medical professionals. Oncotarget gives others the opportunity to become part of the Oncotarget community through new article submission.
InnovaCare Health is an amazing company ran by CEO Rick Shinto and COO/CAO Penelope Kokkinides whom are very experienced in their fields of work. This service serves the purpose of providing affordable health care to it’s many customers worldwide. InnovaCare Health offers quality healthcare for people on health plans such as Medicare Advantage and Medicaid Programs by creating models that are sustainable, cost-effective and fully integrated with most of today’s advanced technology that some other healthcare providers may not offer. This company is also a main leader when it comes to providing some of the best Physician Practice Services. InnovaCare Health is the best choice, all around!
InnovaCare Health’s CEO Rick Shinto has over twenty years of experience in clinical and operational managed healthcare. He has been in the healthcare industry for many years. Penelope Kokkinides & DR. Rick Shinto has held quite a few prestigious titles within the span of his career prior to joining InnovaCare Health including such titles as; the President and CEO of Aveta Inc., Chief Medical Officer of NAMM California and Chief Medical officer as well as the Chief Operating Officer of the Medical Pathways Management System. Shinto started his medical tenure as a Pulmonologist, which is a pulmonary disease specialist, and Internist, which is a specialist in internal medicine. DR. Rick Shinto could be, in some sense, considered overqualified for his positions – but that is, in turn, what makes him the best candidate for his career field. Shinto has an (MBA) from the University of Redlands, a (BS) from the University of California at Irvine and he is M.D accredited.
The COO/CAO of InnovaCare Health is Penelope Kokkinides. Kokkinides also has more than twenty years of experience in her field. Kokkinides specializes in Medicare and Medicaid and the managed care industry. She also has quite an extensive knowledge and expertise in developing clinical programs and managing healthcare processes and operations. Penelope focuses on things such as improving efficiencies and organizational infrastructure. Kokkinides has served in quite a chunk of important roles such as; Executive Vice President and Chief Operating Officer for CenterLight Healthcare, Chief Operating Officer of TouchStone Health and the Corporate Vice President for Care Management and Disease Management at AmeriChoice. Penelope is accredited with a Master’s Degree in Social Work from New York University, a Bachelor’s Degree in Biological Science from Binghampton University and a Master’s Degree in Public Health from Columbia University School and to know more click here